Invention Grant
- Patent Title: Genetic suppression and replacement
- Patent Title (中): 遗传抑制和替代
-
Application No.: US12710343Application Date: 2010-02-22
-
Publication No.: US08551970B2Publication Date: 2013-10-08
- Inventor: Gwenyth Jane Farrar , Peter Humphries , Paul Francis Kenna
- Applicant: Gwenyth Jane Farrar , Peter Humphries , Paul Francis Kenna
- Applicant Address: IE Dublin
- Assignee: Optigen Patents Limited
- Current Assignee: Optigen Patents Limited
- Current Assignee Address: IE Dublin
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: GB9606961.2 19960402
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K38/00 ; A01N43/04 ; C07H21/04 ; C12Q1/68

Abstract:
Methods and agents for suppressing expression of a mutant allele of a gene and providing a replacement nucleic acid are provided. The methods of the invention provide suppression effectors such as, for example, antisense nucleic acids, ribozymes, or RNAi, that bind to the gene or its RNA. The invention further provides for the introduction of a replacement nucleic acid with modified sequences such that the replacement nucleic acid is protected from suppression by the suppression effector. The replacement nucleic acid is modified at degenerate wobble positions in the target region of the suppression effector and thereby is not suppressed by the suppression effector. In addition, by altering wobble positions, the replacement nucleic acid can still encode a wild type gene product. The invention has the advantage that the same suppression strategy could be used to suppress, in principle, many mutations in a gene. Also disclosed is a transgenic mouse that expresses human rhodopsin (modified replacement gene) and a transgenic mouse that expresses a suppression effector targeting rhodopsin. Also disclosed in intraocular administration of siRNA.
Public/Granted literature
- US20110190371A1 GENETIC SUPPRESSION AND REPLACEMENT Public/Granted day:2011-08-04
Information query